General Information

Clinical Trials R&D Tax Incentives

May 29th, 2013

A report of Australian clinical trial costs is flawed according to Industry claims. The report on the global competitiveness of 14 countries came out this time last year, in which Australia was ranked as the second most expensive country to run clinical trials. Australian R&D Industry representatives are now making noise in response to the report. The report rankings were based on areas such as labour costs, transport, facility lease costs and utilities such as electricity. Exact data sources are unclear […]

Read More

Another R&D Boost for Australian Mining

April 26th, 2013

Perth based copper-gold explorer, Empire Resources Ltd has received an R&D Tax offset payment totalling AUD $498,631. The Government support breaks down to an R&D Tax offset payment for the metallurgical and processing techniques used by the company to evaluate and advance the high grade A Zone deposit at its wholly-owned Yuinmery copper-gold project. Managing Director, Mr David Sargeant said “The scale of the payment is also such that it provides a substantial financial injection into Empire, rewarding shareholders’ faith […]

Read More

New Quarterly R&D Tax Credits for cash-strapped SMEs released

April 17th, 2013

From 1 January 2014, the R&D quarterly credits regime will be a new option for small cash-strapped companies wishing to claim under the R&D tax incentive. On Monday, Treasury released its proposed workings of the regime. It will allow companies eligible for the R&D refundable tax offset to obtain the benefit of the offset on a quarterly basis during an income year, rather than waiting until an income tax return is assessed.   Are you eligible for quarterly credits? To qualify for […]

Read More

HURRY! – 18 DAYS UNTIL R&D TAX INCENTIVES DEADLINE

April 11th, 2013

The April 30 R&D Tax Incentive deadline (for June balancing companies) is fast approaching and companies must ensure they register all R&D activities to be eligible for the 43.5% refundable tax offset. The program is open to firms of all sizes in all sectors who are conducting eligible R&D. If your company has an aggregated turnover of less than $20 million per annum you could be entitled to the cash refund of 43.5% of all eligible costs. Click on our eligibility […]

Read More

Categories

Archives

    Email this job